1 |
SHAEFI S, MITTEL A, LOBERMAN D, et al. Off-pump versus on-pump coronary artery bypass grafting-A systematic review and analysis of clinical outcomes[J]. J Cardiothorac Vasc Anesth, 2019,33(1):232-244.
|
2 |
KULIK A, ABREU A M, BORONAT V, et al. Impact of ticagrelor versus aspirin on graft patency after CABG: Rationale and design of the TARGET (ticagrelor antiplatelet therapy to reduce graft events and thrombosis) randomized controlled trial (NCT02053909)[J]. Contemp Clin Trials, 2018, 68:45-51.
|
3 |
PALOMÄKI A,HÄLLBERG V, ALA-KORPELA M,et al. Prompt impact of first prospective statin mega-trials on postoperative lipid management of CABG patients: a 20-year follow-up in a single hospital[J]. Lipids Health Dis, 2016,15(1):124-127.
|
4 |
KATSIKI N, ŽREINER, TEDESCHI REINER E, et al. Improvement of endothelial function by pitavastatin:a meta-analysis[J].Expert Opin Pharmacother,2018,19(3):279-286.
|
5 |
NISHIKIDO T, OYAMA J, KEIDA T, et al. High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: The standard versus high-dose therapy with rosuvastatin for lipid lowering (SARD) trial[J]. J Cardiol, 2016,67(4):340-346.
|
6 |
PARK J B, JUNG J H, YOON Y E, et al. Long-term effects of high-dose pitavastatin on diabetogenicity in comparison with atorvastatin in patients with Metabolic syndrome (LESS-DM): study protocol for a randomized controlled trial[J]. Trials, 2017,18(1):501.
|
7 |
GRUNDY S M, STONE N J. 2018 American heart association/american college of cardiology/multisociety guideline on the management of blood cholesterol-secondary prevention[J].JAMA Cardiol,2019,4(6):589.
|
8 |
CHAN J C, KONG A P, BAO W, et al. Safety of atorvastatin in Asian patients within clinical trials[J]. Cardiovasc Ther, 2016,34(6):431-440.
|
9 |
DEHARO P, PANKERT M, QUILICI J, et al. Safety and effectiveness of the association ezetimibe-statin (E-S) versus high dose rosuvastatin after acute coronary syndrome: the SAFE-ES study[J]. Ann Cardiol Angeiol (Paris), 2014,63(4):222-227.
|
10 |
KULIK A, RUEL M, JNEID H, et al. Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the american heart association[J]. Circulation, 2015, 131(10):927-964.
|
11 |
陆再英, 余保平. 内科学[M]. 2版. 北京:人民卫生出版社,2007:197.
|
12 |
MASANA L, CABRÉA, PLANA N. HPS2-THRIVE results: Bad for niacin/laropiprant, good for ezetimibe?[J]. Atherosclerosis, 2013, 229(2):449-450.
|
13 |
TAGUCHI I, IIMURO S, IWATA H, et al. High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease(REAL-CAD): A randomized superiority trial[J]. Circulation, 2018, 137(19):1997-2009.
|
14 |
YANG Z J, LIU J, GE J P, et al. Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China national diabetes and metabolic disorders study[J]. Eur Heart J, 2012, 33(2):213-220.
|
15 |
H R COLLABORATIVE GROUP, BOWMAN L, HOPEWELL J C,et al. Effects of anacetrapib in patients with atherosclerotic vascular disease[J]. N Engl J Med, 2017, 377(13):1217-1227.
|
16 |
PEDERSEN T R, FAERGEMAN O, KASTELEIN J J P, et al. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial[J]. JAMA, 2005, 294(19):2437-2445.
|
17 |
The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators.High-dose atorvastatin after stroke or transient ischemic attack[J]. N Engl J Med, 2006, 355(6):549-559.
|
18 |
SATTAR N, PREISS D, MURRAY H M, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials[J]. Lancet, 2010,375(9716):735-742.
|
19 |
YEON C J, UNG C C, SOON Y H, et al. Effect of pitavastatin compared with atorvastatin and rosuvastatin on new-onset diabetes mellitus in patients with acute myocardial infarction[J]. Am Cardiol, 2018,166(6):922-928.
|
20 |
HUIJGEN R, BOEKHOLDT S M, ARSENAULT B J, et al. A nested case-control study[J]. J Am Coll Cardiol, 2012, 59(20):1778-1784.
|
21 |
中华医学会心血管病学分会流行病学组, 中国医师协会心血管内科医师分会, 中国老年学学会心脑血管病专业委员会. 糖代谢异常与动脉粥样硬化性心血管疾病临床诊断和治疗指南[J]. 中华心血管病杂志, 2015, 43(6):488-506.
|